Why Is an Amphetamine Screen Result So Easy to Misread?
For healthcare organizations and professionals (B2B) · Physician-led · Updated 2026-07-12 · CLIA #45D2048957 · CAP #8722734
"Amphetamines positive" is a class, not a diagnosis. Chiral separation can distinguish the source.CLIA #45D2048957 · CAP #8722734 · Same-day results · Walk-ins welcome
Because the immunoassay reacts to a structural class. A positive may reflect a prescribed stimulant, an over-the-counter compound, or illicit methamphetamine — and the screen cannot tell them apart. LC-MS/MS identifies the specific molecule; and where clinically indicated, chiral (d/l enantiomer) analysis can help distinguish certain sources, because some legitimate products contain the l-isomer while illicit methamphetamine is predominantly d-methamphetamine.
What confirmation adds
| Question | Screen | LC-MS/MS |
|---|---|---|
| Is a stimulant present? | Suggests yes | Confirms |
| Which molecule? | Cannot say | Identifies specifically |
| Prescribed or illicit? | Cannot say | Molecular identity + metabolite pattern; chiral analysis where indicated |
| How much? | No | Quantitative |
Chiral analysis is not a magic wand and it does not resolve every case. It is one more piece of evidence — and it is a great deal more than an immunoassay line.
These results have real consequences for patients — employment, custody, access to prescribed medication. That is exactly why a presumptive positive must not be acted on without definitive confirmation, and why interpretation belongs to a clinician.
FAQ
- Can you distinguish prescribed Adderall from methamphetamine?
- Molecular identification and metabolite patterns, with chiral analysis where indicated, provide the evidence. A clinician interprets it in context.
- How common are false positives on screens?
- Common enough that no consequential decision should rest on one.
- Is chiral testing standard?
- It is available when clinically indicated. It is not a routine add-on and should not be sold as one.
- What is the turnaround?
- See turnaround and logistics.
References
- SAMHSA — Substance Use Treatment Resources
- ASAM — Clinical Guidelines (Appropriate Use of Drug Testing)
- CDC — Clinical Practice Guideline for Prescribing Opioids
- Our CLIA #45D2048957 and CAP #8722734 credentials — verify them yourself
Reach us — privately
No name needed to ask a question. Text is the fastest way to reach us.
Or send your details below — we will reply by text or email during open hours.